65,437 trials
Retinitis Pigmentosa
Primary: Change From Baseline in Best Corrected Visual Acuity (BCVA) in the Study Eye — 48.5; 51.0; 52.7; 4.0 Number of Letters Read Correctly
Rhegmatogenous Macula-off Retinal Detachment
Primary: Percentage of Patients With at Least a 15-Letter Increase From Baseline in Best Corrected Visual Acuity (BCVA) in the Study Eye — 6.7; 6.7; 0 Percentage of Patients
Chlamydia Trachomatis · Neisseria Gonorrhoeae Infection
Primary: APTIMA Combo 2 Assay Accuracy Compared to Infected Status by Sample Type — 104; 18; 3; 1149 participants
Short Bowel Syndrome
Primary: Number of Subjects Achieving a 20% Reduction at Week 28 — 5; 3; 17; 14 Participants
Brain Neoplasms · Surgery · Hyperemia
Primary: Mean Blood Flow Velocity in Middle Cerebral Artery — 63.7; 61.8 cm/s — p=0.554
Idiopathic Parkinson's Disease
Primary: Change From Baseline to Visit 3 in the Assessment of Intensity of Gastrointestinal (GI) Complaints for Any Reason as Per Visual Analogue Scale (VAS) — -26.8 millimeter…
Metastatic Breast Cancer
Primary: Percentage of Participants With an Objective Response as Assessed Through Independent Radiologic Review — 32.7; 32.7 percentage of participants
Recurrent Non-small Cell Lung Cancer · Stage IIIA Non-small Cell Lung Cancer · Stage IIIB Non-small Cell Lung Cancer
Primary: Safety and Tolerability of IMC-A12 in Combination With Erlotinib Hydrochloride as Graded by Common Terminology Criteria for Adverse Event (CTCAE) Version 3.0 (DLTs…
Breast Cancer
Primary: Percentage of Participants With PD or Death as Assessed by an Independent Review Committee (IRC) — 53.5; 61.3 percentage of participants
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 12 — 8.11; 7.90; 7.86; 7.93 percentage of hemoglobin — p=0.7606
Trifunctional Protein Deficiency
Primary: An Outcome of This Study is the Difference in Percent Body Fat (%BF) Between Subjects With a Long-chain Fatty Acid Oxidation Disorder and Normal Controls. — 31.8; 27.2…
Shoulder Pain · Neck Pain · Musculoskeletal Pain
Primary: The Number of Participants Whose Self-reported Pain Rating in the Neck and Shoulder Area on the 0-100 Visual Analog Scale (VAS) Decreased by 30% or More From Baseline to…
Asthma
Primary: Participants With Adverse Events — 9; 12; 0; 0 participants
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Percentage of Patients Who Prefer Genuair Device Versus Handihaler Device at Visit 2 — 68.6; 18.1; 13.3 Percentage of Patients
Glioblastoma Multiforme
Primary: 6-Month Progression-free Survival — 18.8 percentage of participants